Outcomes and Safety Profile of Repeated Progressive Site‐Directed Therapy for Patients With Oligometastatic Castration‐Resistant Prostate Cancer
Dr. Yasuhisa Fujii is an editorial board member of International Journal of Urology and co-authors of this article. To minimize bias, he is excluded from all editorial decision-making related to the acceptance of this article for publication.
Authors
- Daigoro Matsubara
- Yosuke Yasuda (ORCID: https://orcid.org/0000-0001-5427-1680)
- Soichiro Yoshida
- Ryoichi Yoshimura (ORCID: https://orcid.org/0000-0001-9435-1503)
- Yasuhisa Fujii (ORCID: https://orcid.org/0000-0002-6761-3229)
- Taro Takahara
Institutions
- Tokyo Institute of Technology (JP)
- Tokyo Institute of Psychiatry (JP)
- Innovative Research (United States) (US)
Publication Details
- Journal
- International Journal of Urology
- Published
- 2025-10-01
- DOI
- https://doi.org/10.1111/iju.70253
- Citations
- 1
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 1.52